Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice

Journal of Lipid Research

Volumn 43, Issue 6, 2002, Pages 872-877

  Kako, Yuko ^a   Massé, Maureen ^a   Huang, Li Shin ^a   Tall, Alan R ^a   Goldberg, Ira J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Diabetes; Glucose; Hypercholesterolemia; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; STREPTOZOCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DNA MODIFICATION; GENE DELETION; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 1; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ARTERIOSCLEROSIS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; METABOLISM;

ANIMAL; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CARRIER PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; HUMAN; LIPOPROTEIN LIPASE; LIPOPROTEINS; MICE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; CHOLESTEROL ESTER TRANSFER PROTEINS; GLYCOPROTEINS; HUMANS;

EID: 0035988344     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Diabetes and atherosclerosis: An epidemiologic view
2. George Lyman Duff memorial lecture. Atherogenesis in diabetes
3. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
4. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial
7. Are predictors of coronary heart disease and lowerextremity arterial disease in type I diabetes the same? A prospective study
8. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: UK Prospective Diabetes Study (UKPDS: 23)
9. The effect of alloxan diabetes on experimental atherosclerosis in the rabbits
10. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice
11. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet
12. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
13. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice
14. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
15. Cardiovascular disease in diabetes mellitus type 2: A potential role for novel cardiovascular risk factors
16. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice
17. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
18. Increased atherosclerosis in streptozotocin-induced diabetic mice
19. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo
20. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss
21. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
22. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes
23. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis
24. Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma
25. Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues
26. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans
27. Hepatic uptake of chylomicron remnants
28. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
29. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
30. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion
31. LDL particle size: Effects on apoprotein B structure, receptor recognition, and atherosclerosis
32. A mouse model with features of familial combined hyperlipidemia
33. The biology of the receptor for advanced glycation end products and its ligands
34. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
35. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice